Elysium Health Email Format
Biotechnology ResearchNew York, United States51-200 Employees
Elysium Health is a New York-based biotechnology research company focused on translating scientific advances into health products aimed at supporting healthy aging. Its development approach spans research and development, preclinical studies, and human clinical trials to demonstrate safety and efficacy of compounds derived from nature. The company is guided by a Scientific Advisory Board that includes Nobel Prize laureates and experts in chemistry, physiology, neuroscience, biochemistry, and related fields. Basis, the company’s first product, is a proprietary two-ingredient formulation shown in clinical studies to raise NAD+ levels, a molecule essential for energy production, DNA maintenance, and circadian regulation. In March 2025, Elysium Health launched COFACTOR, a collagen supplement designed to support collagen production and address aging-related declines.